A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer
NCT05919095
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Unresectable Gallbladder Cancer
Interventions
DRUG:
Carrilizumab plus GEMOX
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University